Class ITerminatedD-1168-2022
Drug recall · June 15, 2022
Tacrolimus recall
Why: Subpotent drug
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
- Lots / codes
Lot #: 04272022@35, BUD: 7/7/2022.
- Quantity
- 950 mLs in 1x8 oz and 2x16 oz bottles.
- Company
- Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy, Berkeley, CA
- Distribution
- CA
- Initiated
- April 15, 2022 · Voluntary: Firm initiated
- Classified
- June 27, 2022
- Reported
- June 15, 2022
- Ended
- November 7, 2022
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tacrolimus
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.